Treatment Options for Neuroblastoma
Patients First Treated for Intermediate-Risk Neuroblastoma
Treatment for recurrentneuroblastoma that is found in one place in the body may include the following:
- Surgery, with or without chemotherapy.
- A clinical trial of surgery and more courses of chemotherapy.
- A clinical trial of a new treatment.
For recurrent neuroblastoma that has spread to other parts of the body, treatment is usually high-dose chemotherapy, stem cell transplant, and 13-cis retinoic acid.
Patients First Treated for High-Risk Neuroblastoma
Treatment for recurrentneuroblastoma in patients first treated for high-risk neuroblastoma may include the following:
- A second course of high-dose chemotherapy and stem cell transplant.
Because there is no standard treatment for recurrentneuroblastoma in patients first treated for high-risk neuroblastoma, patients may want to consider a clinical trial. For information about clinical trials, please see the NCI Web site.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with neuroblastoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.